About Me
Jonah Shulman, MD, is Assistant Professor of Medicine (Hematology and Medical Oncology) at the Icahn School of Medicine at Mount Sinai. Dr. Shulman treats patients with all subtypes of lymphoma as well as chronic lymphocytic leukemia at The Ruttenberg Treatment Center.
Dr. Shulman is a co-investigator on all lymphoma clinical trials at the Mount Sinai Health System, aimed at developing new therapies for improved outcomes. He works with his patients to ensure comprehensive, patient-centered approaches to their care.
Dr. Shulman was the senior author of the chapter on Hodgkin Lymphoma for the oncology section of the 2019 Mount Sinai Expert Guide. He is a regular lecturer on lymphoma for medical students.
Language
Position
ASSISTANT PROFESSOR | Medicine, Hematology and Medical OncologyHospital Affiliations
- Mount Sinai Beth Israel
- The Mount Sinai Hospital
- New York Eye and Ear Infirmary of Mount Sinai
- Mount Sinai Morningside and Mount Sinai West
About Me
Jonah Shulman, MD, is Assistant Professor of Medicine (Hematology and Medical Oncology) at the Icahn School of Medicine at Mount Sinai. Dr. Shulman treats patients with all subtypes of lymphoma as well as chronic lymphocytic leukemia at The Ruttenberg Treatment Center.
Dr. Shulman is a co-investigator on all lymphoma clinical trials at the Mount Sinai Health System, aimed at developing new therapies for improved outcomes. He works with his patients to ensure comprehensive, patient-centered approaches to their care.
Dr. Shulman was the senior author of the chapter on Hodgkin Lymphoma for the oncology section of the 2019 Mount Sinai Expert Guide. He is a regular lecturer on lymphoma for medical students.
Language
Position
ASSISTANT PROFESSOR | Medicine, Hematology and Medical OncologyHospital Affiliations
- Mount Sinai Beth Israel
- The Mount Sinai Hospital
- New York Eye and Ear Infirmary of Mount Sinai
- Mount Sinai Morningside and Mount Sinai West
About Me
Jonah Shulman, MD, is Assistant Professor of Medicine (Hematology and Medical Oncology) at the Icahn School of Medicine at Mount Sinai. Dr. Shulman treats patients with all subtypes of lymphoma as well as chronic lymphocytic leukemia at The Ruttenberg Treatment Center.
Dr. Shulman is a co-investigator on all lymphoma clinical trials at the Mount Sinai Health System, aimed at developing new therapies for improved outcomes. He works with his patients to ensure comprehensive, patient-centered approaches to their care.
Dr. Shulman was the senior author of the chapter on Hodgkin Lymphoma for the oncology section of the 2019 Mount Sinai Expert Guide. He is a regular lecturer on lymphoma for medical students.
Language
Position
ASSISTANT PROFESSOR | Medicine, Hematology and Medical OncologyHospital Affiliations
- Mount Sinai Beth Israel
- The Mount Sinai Hospital
- New York Eye and Ear Infirmary of Mount Sinai
- Mount Sinai Morningside and Mount Sinai West
Education
MD, Albert Einstein College of Medicine
Residency, Internal Medicine
Mount Sinai Beth Israel
Fellowship, Hematology-Oncology
Mount Sinai Beth Israel
Certifications
Hematology
Medical Oncology
American Board of Internal Medicine
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Shulman did not report having any of the following types of financial relationships with industry during 2022 and/or 2023: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Mount Sinai Doctors
Accepting New Patients
